Soft tissue sarcomas (STS) are a group of rare, malignant tumors that arise from the body’s soft tissues, such as fat, muscle, blood vessels, tendons, and the lining of joints and organs. As a result of the rarity of these tumors, there have been few studies that have looked at the best way to follow patients with STS after their initial treatment.
Follow-up Guidelines for Soft Tissue Sarcomas
The National Comprehensive Cancer Network (NCCN) has published guidelines for follow-up care for patients with STS. These guidelines recommend that patients have regular follow-up visits with their oncologist within the first five years after their initial treatment. The frequency of these visits should be determined by the physician, based on the patient’s individual circumstances and risk factors.
At each follow-up visit, the patient should receive a physical exam, including palpation of the tumor site and other areas of the body for any new lumps or masses. Additionally, imaging studies such as CT or MRI scans should be performed to monitor for any signs of recurrence. Blood tests, including a complete blood count (CBC), can also be used to help detect any abnormalities.
Long-term Follow-up for Soft Tissue Sarcomas
After the initial 5-year period, the NCCN recommends that patients continue to receive regular follow-up visits on an annual basis. These visits should include physical exams, imaging studies, and blood tests as described above. If the patient’s risk of recurrence is considered to be high, then the follow-up visits should be more frequent.
The goal of long-term follow-up is to detect any signs of recurrence as early as possible, so that treatment can be started promptly. Early detection is important in order to improve the patient’s outcomes and quality of life.
Conclusion
Patients with soft tissue sarcomas should receive regular follow-up visits with their oncologist for at least 5 years after their initial treatment. After this initial 5-year period, patients should continue to receive annual follow-up visits. These visits should include physical exams, imaging studies, and blood tests in order to detect any signs of recurrence as early as possible. Early detection is key to improving the patient’s outcomes and quality of life.